Better Therapeutics Inc (BTTX)

Currency in USD
0.01
0.00(0.00%)
Closed·
BTTX Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
Trading near 52-week Low
BTTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.010.01
52 wk Range
0.010.01
Key Statistics
Prev. Close
-
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-0.01
Volume
-
Average Volume (3m)
510
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BTTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Better Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Better Therapeutics Inc Company Profile

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company’s clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Compare BTTX to Peers and Sector

Metrics to compare
BTTX
Peers
Sector
Relationship
P/E Ratio
0.0x−1.9x−0.5x
PEG Ratio
0.000.010.00
Price/Book
0.0x1.6x2.6x
Price / LTM Sales
0.0x2.7x3.3x
Upside (Analyst Target)
0.0%30.5%43.5%
Fair Value Upside
Unlock16.1%6.8%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / -0.27
Revenue / Forecast
-- / 701.00K
EPS Revisions
Last 90 days

BTTX Income Statement

FAQ

What Stock Exchange Does Better Therapeutics Trade On?

Better Therapeutics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Better Therapeutics?

The stock symbol for Better Therapeutics is "BTTX."

What Is the Better Therapeutics Market Cap?

As of today, Better Therapeutics market cap is 5.45K.

What Is Better Therapeutics's Earnings Per Share (TTM)?

The Better Therapeutics EPS (TTM) is -1.08.

When Is the Next Better Therapeutics Earnings Date?

Better Therapeutics will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is BTTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Better Therapeutics Stock Split?

Better Therapeutics has split 0 times.

How Many Employees Does Better Therapeutics Have?

Better Therapeutics has 54 employees.

What is the current trading status of Better Therapeutics (BTTX)?

As of 09 Aug 2025, Better Therapeutics (BTTX) is trading at a price of 0.01, with a previous close of 0.00. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 0.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.